The Lancet. Psychiatry, 2215-0366

Journal

Related Publications
  1. Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults

    Dehue, T., Bijl, D., de Winter, M., Scheepers, F., Vanheule, S., van Os, J., Verhaeghe, P. & Verhoeff, B., 1-Jun-2017, In : The Lancet Psychiatry. 4, 6, p. 438-439 2 p.

    Research output: Contribution to journalLetterAcademicpeer-review

  2. High-potency cannabis and incident psychosis: correcting the causal assumption

    Sommer, I. E. & van den Brink, W., Jun-2019, In : The Lancet. Psychiatry. 6, 6, p. 464-465 2 p.

    Research output: Contribution to journalLetterAcademicpeer-review

  3. Antipsychotic treatments: who is really failing here? Reply

    Kahn, R. S. & Sommer, I. E., Oct-2018, In : The Lancet. Psychiatry. 5, 10, p. 785-786 2 p.

    Research output: Contribution to journalLetterAcademicpeer-review

  4. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

    OPTIMISE Study Grp, Oct-2018, In : The Lancet. Psychiatry. 5, 10, p. 797-807 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Preventive strategies for mental health

    Arango, C., Diaz-Caneja, C. M., McGorry, P. D., Rapoport, J., Sommer, I. E., Vorstman, J. A., McDaid, D., Marin, O., Serrano-Drozdowskyj, E., Freedman, R. & Carpenter, W., 1-Jul-2018, In : The Lancet. Psychiatry. 5, 7, p. 591-604 14 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

View all (15) »

ID: 19941134